🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Material Elimination

According to TikTok, the platform has taken down violative material and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Activities

Research also found groups with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.

After moments of entering one group, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, posts display black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they cannot confirm. Although the research behind this drug is valid, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.